Business Standard: In quality crackdown, US drug regulator finds Indian companies critically ill
Business Standard: In quality crackdown, US drug regulator finds Indian companies critically ill September 24, 2013 By: Sushmi Day The Indian pharmaceutical industry appears to be in the line of fire. The country’s drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has ...
Continue Reading →